vTv Therapeutics Inc.

NASDAQ: VTVT · Real-Time Price · USD
15.46
1.43 (10.19%)
At close: Aug 15, 2025, 3:58 PM
15.73
1.75%
After-hours: Aug 15, 2025, 04:10 PM EDT

vTv Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
17K 17K 1.02M 991K 991K 1M n/a 18K 18K 18K 2.02M 2.02M 5.02M 5.02M 4M 10.39M 7.4M 7.39M
Cost of Revenue
53K 76K 89K 90K 90K 90K 90K 90K 92K 157K 158K 140K 2.5M 4.85M 7.93M 10.46M 9.84M 9.91M
Gross Profit
-36K -59K 928K 910K 910K 919K -81K -72K -74K -139K 1.86M 1.88M 2.52M 171K -3.92M -61K -2.44M -2.52M
Operating Income
-17.9M -25.06M -24.18M -24M -22.86M -23.7M -25.5M -27.14M -27.46M -23.49M -22.54M -27.31M -23.22M -23.86M -21.66M -8.72M -9.95M -9.49M
Interest Income
1.54M 1.82M 1.56M 1.22M 851K 451K 472K 536K 555K 452K 352K 200K 50K n/a 1K 1K 1K 1K
Pretax Income
-22.54M -22.9M -22.61M -22.61M -25.31M -26.11M -25.97M -27.61M -24.54M -21.42M -24.87M -28.27M -24.16M -20.91M -17.62M -6.53M -7.41M -11.56M
Net Income
-19.55M -18.69M -18.46M -18.31M -20.18M -20.62M -20.25M -22.66M -20.27M -17.8M -22.73M -23.89M -20.71M -18.17M -12.99M -4.81M -5.26M -8.02M
Selling & General & Admin
13.25M 13.35M 13.65M 13.54M 12.81M 12.4M 11.91M 11.73M 11.82M 10.34M 12.2M 15.53M 15.12M 15.53M 12.34M 8.66M 7.51M 6.96M
Research & Development
12.39M 11.73M 11.52M 11.43M 11.03M 12.28M 13.6M 15.42M 15.65M 13.17M 12.36M 13.79M 13.12M 13.35M 13.32M 10.46M 9.84M 9.91M
Other Expenses
-22K -22K -22K -23K -23K -23K -23K n/a n/a -114K -114K -114K -114K n/a -1.65M -1.8M -990K -1.55M
Operating Expenses
25.62M 25.05M 25.15M 24.95M 23.81M 24.66M 25.48M 27.15M 27.47M 23.5M 24.56M 29.32M 28.24M 28.88M 25.67M 19.12M 17.35M 16.88M
Interest Expense
n/a n/a n/a 7K 11K 13K 13K 12K 16K 14K 15K 15K 13K 13K 12K 73K 302K 524K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.92M 25.07M 25.2M 25M 23.86M 24.7M 25.5M 27.15M 27.47M 23.5M 24.56M 29.32M 28.24M 28.88M 25.67M 19.12M 17.35M 16.88M
Income Tax Expense
n/a n/a 100K 100K 100K 100K n/a -199.8K -199.8K -199.8K 200.00 200K 300K 300K 115K 115K 15K 15K
Shares Outstanding (Basic)
6.59M 6.58M 5.77M 5.46M 6.4M 4.14M 2.08M 2.04M 2.04M 2.04M 2.04M 2.01M 1.76M 1.67M 1.67M 1.53M 1.47M 1.41M
Shares Outstanding (Diluted)
6.59M 6.58M 5.77M 5.46M 6.4M 4.14M 2.08M 2.04M 2.04M 2.04M 2.04M 2.01M 1.76M 1.67M 1.67M 1.53M 1.47M 1.41M
EPS (Basic)
-3.2 -3.09 -3.49 -4.53 -6.92 -8.87 -9.91 -11.13 -9.98 -9.01 -12.43 -13.76 -12.35 -10.97 -8.34 -3.18 -3.74 -6.28
EPS (Diluted)
-3.2 -3.09 -3.49 -4.53 -6.92 -8.87 -9.91 -11.13 -9.98 -9.01 -12.43 -13.76 -12.35 -10.97 -8.34 -3.18 -3.74 -6.28
EBITDA
-16.44M -22.83M -22.22M -22.22M -24.92M -25.72M -27.52M -29.17M -26.09M -22.97M -24.77M -28.16M -24.06M -20.81M -17.52M -6.21M -6.87M -10.79M
EBIT
-16.49M -22.9M -22.31M -22.31M -25.01M -25.81M -27.61M -29.26M -26.18M -23.06M -24.86M -28.25M -24.15M -20.9M -17.6M -6.3M -6.96M -10.88M
Depreciation & Amortization
53K 76K 89K 90K 90K 90K 90K 90K 92K 91K 92K 91K 89K 89K 89K 89K 90K 90K